European Monitoring Centre for Drugs and Drug Addiction. (2018) EMCDDA–Europol 2017 annual report on the implementation of Council Decision 2005/387/JHA, implementation reports. Luxembourg: Publications Office of the European Union.
| Preview | Title | Contact |
|---|---|---|
|
PDF
- Published Version
613kB |
- Background to this report
- Overview
- Implementation arrangements and cooperation with the European Union Pharmacovigilance system
- Specific implementation arrangements
-
-
- Assistance to national early warning systems
- Annual meeting of the EU Early Warning System Network
- Strengthening early warning and response
- Links with forensic science and toxicology networks
- Supporting activities and cooperation with third countries
- Cooperation with international organisations
- Europol
- Cooperation with the European Medicines Agency and the pharmacovigilance system
- New legislation
- Cooperation with ECHA, EFSA and ECDC
-
- Core activities
- Early warning activities (Article 4)
- New psychoactive substances detected and formally notified in 2017
- Reporting tools and 2016 seizure data
- Public health-related alerts
- EMCDDA–Europol Joint Reports (Article 5)
- Risk assessments (Article 6)
- Early warning activities (Article 4)
- Conclusions
- Publications
- Annex 1. New psychoactive substances notified for the first time in 2017 under the terms of Council Decision 2005/387/JHA
- Annex 2. List of risk communications issued to the EU Early Warning System Network in 2017 under the terms of Council Decision 2005/387/JHA
Item Type
Report
Publication Type
Irish-related, International, Report
Drug Type
Substances (not alcohol/tobacco)
Intervention Type
Crime prevention, Policy
Date
August 2018
Publisher
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Luxembourg
EndNote
Accession Number
HRB (Electronic Only)
Repository Staff Only: item control page